JEFFREY D BACHTEL

Allopathic & Osteopathic Physicians|Family Medicine TALLMADGE, OH NPI 1013974997

General Payments — all program years on this page

$3,731.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 283
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $401.29 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $401.2921

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,164.98100
2019 $1,174.0496
2020 $541.4538
2021 $12.081
2022 $154.089
2023 $284.0718
2024 $401.2921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096833753 Novo Nordisk Inc $14.05 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101317580 E.R. Squibb & Sons, L.L.C. $13.26 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103260489 ABBVIE INC. $20.05 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103260491 ABBVIE INC. $15.36 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103260493 ABBVIE INC. $20.79 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103260495 ABBVIE INC. $17.58 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104595268 AstraZeneca Pharmaceuticals LP $14.94 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105394409 AstraZeneca Pharmaceuticals LP $15.87 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111521879 Amgen Inc. $26.57 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117791400 Corcept Therapeutics $25.83 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117791474 Corcept Therapeutics $21.68 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117839085 Boehringer Ingelheim Pharmaceuticals, Inc. $17.77 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798398 Abbott Laboratories $24.33 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798400 Abbott Laboratories $20.25 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798402 Abbott Laboratories $23.20 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131167654 PFIZER INC. $19.99 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131462387 PFIZER INC. $18.89 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139267238 Astellas Pharma US Inc $17.26 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139330002 Astellas Pharma US Inc $14.28 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144598306 Xeris Pharmaceuticals, Inc. $16.99 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153307469 Dexcom, Inc. $22.35 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.